Tennessee Oncology is one of the nation’s largest community-based cancer care specialists and home to one of the leading clinical trial networks in the country. Established 1976 in Nashville, Tennessee Oncology’s mission remains unchanged: To provide access to high quality cancer care and the expertise of clinical research for all patients at convenient locations within their community and close to their home. To this day, our growing network of physicians and number of locations is based on this mission. In 2018, Tennessee Oncology joined OneOncology, a partnership of oncologists and industry leading experts driving the future of community-based cancer care in the United States, as a founding practice partner. Physicians specializing in gynecologic oncology, palliative care, radiation oncology, and health psychology comprise our group. Tennessee Oncology provides a full range of diagnostic services, including oncology specific expertise in PET/CT and laboratory services. Clinic locations provide on-site chemotherapy treatments so that patients receive care in their community and close to their home. Our physicians utilize the latest in molecular diagnostics and profiling to choose treatments specific to the genetics of your cancer. Oncology research is the largest area of new drug development. Self -administered medications, those taken by mouth or injected by the patient, comprise approximately 40% of these investigative medications. Tennessee Oncology’s in house pharmacy, Park Pharmacy, stocks oncology and hematology medications not readily available at community retail pharmacies. A URAC accredited Specialty Pharmacy, Park provides insurance and benefits investigation, prior authorization services for insurance coverage, co-pay assistance through manufacturer or foundation programs, extensive medication education, and access to a pharmacist 24 hours a day, 7 days a week.
SaaS Adoption
SaaS Adoption indicates the level of adoption by this company of software as a service services.
Cloud Adoption
Cloud Adoption indicates the level of adoption by this company of cloud services.
IT Footprint
IT Footprint gives a relative indication of how much IT services this company consumes.
IT Spend
IT Spend shows roughly how much this client spends on IT per year in USD.
Enlyft tracks the use of over 15,000 technologies and has proprietary data on over 18 million companies worldwide.
Tennessee Oncology uses 5 different technologies from 37 different vendors. They have above average use of several technologies including VMware vSphere, Apple IOS and Python.
Tennessee Oncology uses products from 37 different product categories. They are particularly heavy users of products in Enterprise HR Management, Operating Systems, and Healthcare.
Enlyft tracks the use of over 15,000 technologies and has proprietary data on over 18 million companies worldwide.
Technology | Category | Vendor | Usage |
---|---|---|---|
VMware vSphere | Virtualization Platforms | VMware, Inc | |
Apple IOS | Operating Systems | Apple, Inc. | |
Python | Programming Languages | Python Software Foundation | |
Allscripts | Healthcare | Allscripts | |
Workday Human Capital Management | Enterprise HR Management | Workday |
What other companies use VMware vSphere?
Who are the biggest users of Operating Systems?
What countries, industries, and company sizes are most likely to use Python?